The global enzyme replacement therapy market is witnessing growth as enzyme-based treatments remain an important therapeutic approach for managing certain rare and inherited disorders. The market was valued at US$ 9,673.39 million in 2021 and is projected to reach US$ 15,184.70 million by 2028. The market is estimated to grow at a compound annual growth rate of 6.8% from 2022 to 2028,...
The Non-Alcoholic Fatty Liver Disease (NAFLD) Market is expanding rapidly as pharmaceutical developers, healthcare systems, diagnostic providers, and payers accelerate efforts to detect silent liver fibrosis early, halt progression to non-alcoholic steatohepatitis (NASH/MASH) and cirrhosis, and deploy targeted disease-modifying therapies. Growth is supported by escalating global obesity and...
Dialysis Concentrate Market growth is supported by technological improvements in dialysis machines and concentrate delivery systems. Automated mixing and proportioning technologies help maintain consistent dialysate preparation and reduce the possibility of errors during treatment.
The global Dialysis Concentrate Market was valued at US$ 3.17 billion in 2025 and is expected to reach US$ 5.1...
Veterinary Diagnostics Market demand is rising as food safety and animal disease surveillance receive greater attention. Diagnostic testing supports the monitoring of livestock health and helps identify infections that could affect agricultural productivity and the safety of animal-derived food products.
The global veterinary diagnostics market was valued at US$ 4,045.50 million in 2022 and is...
The Global Endocrine Testing Market is experiencing steady growth as the demand for accurate hormone-related diagnostics increases across healthcare systems. The market was valued at US$ 3.14 billion in 2025 and is expected to reach US$ 4.81 billion by 2034, registering a compound annual growth rate (CAGR) of 4.85% during 2026–2034. Endocrine testing plays an important role in identifying...
North America represents one of the largest hubs for dietary supplements consumption, driven by increasing awareness of preventive healthcare, fitness culture, and nutritional wellness. Consumers are actively seeking products that support immunity, heart health, digestive wellness, energy management, and overall well-being. The availability of innovative formulations, strong retail...
The Global Weight Reduction Medicine Market is witnessing significant growth due to increasing awareness of obesity-related health risks and the rising demand for effective weight management treatments. Obesity has become a major global health concern, contributing to several chronic conditions, including diabetes, cardiovascular diseases, hypertension, and metabolic disorders. Growing...
The global enzyme replacement therapy market is witnessing steady growth, driven by the rising prevalence of lysosomal storage diseases and increasing regulatory approvals for treatments targeting rare disorders. The enzyme replacement therapy market is expected to grow from US$ 9,673.39 million in 2021 to US$ 15,184.70 million by 2028. The market is estimated to register a compound annual...
The Global Longevity Market was valued at US$ 6.23 billion in 2025 and is expected to reach US$ 19.25 billion by 2034. The market is estimated to record a compound annual growth rate of 13.35% during 2026–2034. Increasing interest in healthy aging, rising investments in biotechnology research, and advancements in regenerative medicine are creating significant opportunities for companies...
The global feed additives for veterinary market is experiencing strong commercial momentum across the animal health, livestock nutrition, and veterinary pharmaceutical sectors. Veterinary feed additives—comprising specialized vitamins, amino acids, minerals, probiotics, prebiotics, and therapeutic specialty additives—are incorporated into animal feed formulations to prevent disease,...
The Biochemistry analyzers have become essential in modern laboratories for measuring enzymes, proteins, electrolytes, glucose, and other biochemical markers. Their increasing role in disease detection and patient monitoring is supporting broader adoption across hospitals, diagnostic centers, pharmaceutical and biotechnology companies, research institutes, and contract research organizations....
Hyperlipidemia is one of the most common metabolic disorders worldwide and a major risk factor for cardiovascular diseases, stroke, and peripheral artery disease. The condition is characterized by elevated levels of cholesterol and triglycerides in the bloodstream, necessitating long-term treatment and monitoring. Growing awareness regarding cardiovascular health, increasing screening programs,...